Showing 1 - 15 results of 15 for search 'Nathalie Strub Wourgaft', query time: 0.05s Refine Results
  1. 1
    Inclusion of women susceptible to and becoming pregnant in preregistration clinical trials in low- and middle-income countries: A proposal for neglected tropical diseases.

    Inclusion of women susceptible to and becoming pregnant in preregistration clinical trials in low- and middle-income countries: A proposal for neglected tropical diseases. by Monique Couderc-Pétry, Elisabeth Eléfant, Monique Wasunna, Alwyn Mwinga, Nilima A Kshirsagar, Nathalie Strub-Wourgaft

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    A new patient registry for Chagas disease.

    A new patient registry for Chagas disease. by Peter Hotez, Maria Elena Bottazzi, Nathalie Strub-Wourgaft, Sergio Sosa-Estani, Faustino Torrico, Leire Pajín, Marcelo Abril, Javier Sancho

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Systematic review of clinical trials assessing the therapeutic efficacy of visceral leishmaniasis treatments: A first step to assess the feasibility of establishing an individual patient data sharing platform.

    Systematic review of clinical trials assessing the therapeutic efficacy of visceral leishmaniasis treatments: A first step to assess the feasibility of establishing an individual p... by Jacob T Bush, Monique Wasunna, Fabiana Alves, Jorge Alvar, Piero L Olliaro, Michael Otieno, Carol Hopkins Sibley, Nathalie Strub Wourgaft, Philippe J Guerin

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Definitions matter: Heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis.

    Definitions matter: Heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis. by Philippe J Guérin, Alistair R D McLean, Sumayyah Rashan, AbdulAzeez Lawal, James A Watson, Nathalie Strub-Wourgaft, Nicholas J White

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Definitions matter: Heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis

    Definitions matter: Heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis by Philippe J. Guérin, Alistair R. D. McLean, Sumayyah Rashan, AbdulAzeez Lawal, James A. Watson, Nathalie Strub-Wourgaft, Nicholas J. White

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    A new patient registry for Chagas disease

    A new patient registry for Chagas disease by Peter Hotez, Maria Elena Bottazzi, Nathalie Strub-Wourgaft, Sergio Sosa-Estani, Faustino Torrico, Leire Pajín, Marcelo Abril, Javier Sancho, Igor C. Almeida

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    The Chagas disease study landscape: A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data platform.

    The Chagas disease study landscape: A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual partici... by Brittany J Maguire, Prabin Dahal, Sumayyah Rashan, Roland Ngu, Anca Boon, Colin Forsyth, Nathalie Strub-Wourgaft, Eric Chatelain, Fabiana Barreira, Sergio Sosa-Estani, Philippe J Guérin

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    The drug and vaccine landscape for neglected diseases (2000-11): a systematic assessment

    The drug and vaccine landscape for neglected diseases (2000-11): a systematic assessment by Dr. Belen Pedrique, MD, Nathalie Strub-Wourgaft, MD, Claudette Some, PharmD, Piero Olliaro, MD, Patrice Trouiller, PharmD, Nathan Ford, PhD, Bernard Pécoul, MD, Jean-Hervé Bradol, MD

    Published 2013
    Connect to this object online.
    Book
    Save to List
    Saved in:
  9. 9
    Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh.

    Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh. by Ridwanur Rahman, Vishal Goyal, Rashidul Haque, Kazi Jamil, Abul Faiz, Rasheda Samad, Sally Ellis, Manica Balasegaram, Margriet den Boer, Suman Rijal, Nathalie Strub-Wourgaft, Fabiana Alves, Jorge Alvar, Bhawna Sharma

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  10. 10
    Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, India.

    Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, India. by Vishal Goyal, Sakib Burza, Krishna Pandey, Shambhu Nath Singh, Ravi Shankar Singh, Nathalie Strub-Wourgaft, Vidya Nand Rabi Das, Caryn Bern, Allen Hightower, Suman Rijal, Temmy Sunyoto, Fabiana Alves, Nines Lima, Pradeep Das, Jorge Alvar

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  11. 11
    Operation Warp Speed: implications for global vaccine security

    Operation Warp Speed: implications for global vaccine security by Jerome H Kim, Peter Hotez, Carolina Batista, Onder Ergonul, J Peter Figueroa, Sarah Gilbert, Mayda Gursel, Mazen Hassanain, Gagandeep Kang, Bhavna Lall, Heidi Larson, Denise Naniche, Timothy Sheahan, Shmuel Shoham, Annelies Wilder-Smith, Nathalie Strub-Wourgaft, Prashant Yadav, Maria Elena Bottazzi

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  12. 12
    Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, India.

    Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, India. by Vishal Goyal, Raman Mahajan, Krishna Pandey, Shambhu Nath Singh, Ravi Shankar Singh, Nathalie Strub-Wourgaft, Fabiana Alves, Vidya Nand Rabi Das, Roshan Kamal Topno, Bhawna Sharma, Manica Balasegaram, Caryn Bern, Allen Hightower, Suman Rijal, Sally Ellis, Temmy Sunyoto, Sakib Burza, Nines Lima, Pradeep Das, Jorge Alvar

    Published 2018
    Connect to this object online.
    Book
    Save to List
    Saved in:
  13. 13
    A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia.

    A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia. by Ermias Diro, Severine Blesson, Tansy Edwards, Koert Ritmeijer, Helina Fikre, Henok Admassu, Aderajew Kibret, Sally J Ellis, Clelia Bardonneau, Eduard E Zijlstra, Peninah Soipei, Brian Mutinda, Raymond Omollo, Robert Kimutai, Gabriel Omwalo, Monique Wasunna, Fentahun Tadesse, Fabiana Alves, Nathalie Strub-Wourgaft, Asrat Hailu, Neal Alexander, Jorge Alvar

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  14. 14
    Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial.

    Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial. by Monique Wasunna, Simon Njenga, Manica Balasegaram, Neal Alexander, Raymond Omollo, Tansy Edwards, Thomas P C Dorlo, Brima Musa, Mohammed Hassan Sharaf Ali, Mohammed Yasein Elamin, George Kirigi, Rashid Juma, Anke E Kip, Gerard J Schoone, Asrat Hailu, Joseph Olobo, Sally Ellis, Robert Kimutai, Susan Wells, Eltahir Awad Gasim Khalil, Nathalie Strub Wourgaft, Fabiana Alves, Ahmed Musa

    Published 2016
    Connect to this object online.
    Book
    Save to List
    Saved in:
  15. 15
    Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study

    Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study by Victor Kande Betu Ku Mesu, DPH, Wilfried Mutombo Kalonji, MD, Clélia Bardonneau, MSc, Olaf Valverde Mordt, MSc, Digas Ngolo Tete, MPH, Séverine Blesson, MSc, François Simon, MSc, Sophie Delhomme, MSc, Sonja Bernhard, PhD, Hélène Mahenzi Mbembo, MD, Christian Mpia Moke, MD, Steven Lumeya Vuvu, MMed, Junior Mudji E'kitiak, MD, Felix Akwaso Masa, MD, Melchias Mukendi Ilunga, MD, Dieudonné Mpoyi Muamba Nzambi, MD, Tim Mayala Malu, MD, Serge Kapongo Tshilumbwa, MD, Franck Botalema Bolengi, MD, Mathieu Nkieri Matsho, MD, Crispin Lumbala, MPH, Bruno Scherrer, PhD, Nathalie Strub-Wourgaft, MD, Antoine Tarral, MD

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: